Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified
Clinical trial NCT03276455 · UNKNOWN
Trial details
- NCT number
- NCT03276455
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-15
- Primary completion
- 2020-09-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.